252 related articles for article (PubMed ID: 18056454)
1. Choline kinase down-regulation increases the effect of 5-fluorouracil in breast cancer cells.
Mori N; Glunde K; Takagi T; Raman V; Bhujwalla ZM
Cancer Res; 2007 Dec; 67(23):11284-90. PubMed ID: 18056454
[TBL] [Abstract][Full Text] [Related]
2. RNA interference-mediated choline kinase suppression in breast cancer cells induces differentiation and reduces proliferation.
Glunde K; Raman V; Mori N; Bhujwalla ZM
Cancer Res; 2005 Dec; 65(23):11034-43. PubMed ID: 16322253
[TBL] [Abstract][Full Text] [Related]
3. Down-regulation of mitochondrial F1F0-ATP synthase in human colon cancer cells with induced 5-fluorouracil resistance.
Shin YK; Yoo BC; Chang HJ; Jeon E; Hong SH; Jung MS; Lim SJ; Park JG
Cancer Res; 2005 Apr; 65(8):3162-70. PubMed ID: 15833846
[TBL] [Abstract][Full Text] [Related]
4. Expression profiling of nucleotide metabolism-related genes in human breast cancer cells after treatment with 5-fluorouracil.
Behera RK; Nayak R
Cancer Invest; 2009 Jun; 27(5):561-7. PubMed ID: 19219653
[TBL] [Abstract][Full Text] [Related]
5. 15-hydroxyprostaglandin dehydrogenase is a tumor suppressor of human breast cancer.
Wolf I; O'Kelly J; Rubinek T; Tong M; Nguyen A; Lin BT; Tai HH; Karlan BY; Koeffler HP
Cancer Res; 2006 Aug; 66(15):7818-23. PubMed ID: 16885386
[TBL] [Abstract][Full Text] [Related]
6. Molecular causes of the aberrant choline phospholipid metabolism in breast cancer.
Glunde K; Jie C; Bhujwalla ZM
Cancer Res; 2004 Jun; 64(12):4270-6. PubMed ID: 15205341
[TBL] [Abstract][Full Text] [Related]
7. Noninvasive magnetic resonance spectroscopic pharmacodynamic markers of the choline kinase inhibitor MN58b in human carcinoma models.
Al-Saffar NM; Troy H; RamÃrez de Molina A; Jackson LE; Madhu B; Griffiths JR; Leach MO; Workman P; Lacal JC; Judson IR; Chung YL
Cancer Res; 2006 Jan; 66(1):427-34. PubMed ID: 16397258
[TBL] [Abstract][Full Text] [Related]
8. Molecular characterizations of derivatives of HCT116 colorectal cancer cells that are resistant to the chemotherapeutic agent 5-fluorouracil.
de Angelis PM; Fjell B; Kravik KL; Haug T; Tunheim SH; Reichelt W; Beigi M; Clausen OP; Galteland E; Stokke T
Int J Oncol; 2004 May; 24(5):1279-88. PubMed ID: 15067352
[TBL] [Abstract][Full Text] [Related]
9. Progestins regulate genes that can elicit both proliferative and antiproliferative effects in breast cancer cells.
Purmonen S; Manninen T; Pennanen P; Ylikomi T
Oncol Rep; 2008 Jun; 19(6):1627-34. PubMed ID: 18497975
[TBL] [Abstract][Full Text] [Related]
10. 17Beta-estradiol induces down-regulation of Cap43/NDRG1/Drg-1, a putative differentiation-related and metastasis suppressor gene, in human breast cancer cells.
Fotovati A; Fujii T; Yamaguchi M; Kage M; Shirouzu K; Oie S; Basaki Y; Ono M; Yamana H; Kuwano M
Clin Cancer Res; 2006 May; 12(10):3010-8. PubMed ID: 16707596
[TBL] [Abstract][Full Text] [Related]
11. Y-box binding protein 1 is up-regulated in proliferative breast cancer and its inhibition deregulates the cell cycle.
Yu YN; Yip GW; Tan PH; Thike AA; Matsumoto K; Tsujimoto M; Bay BH
Int J Oncol; 2010 Aug; 37(2):483-92. PubMed ID: 20596676
[TBL] [Abstract][Full Text] [Related]
12. Cellular response to 5-fluorouracil (5-FU) in 5-FU-resistant colon cancer cell lines during treatment and recovery.
De Angelis PM; Svendsrud DH; Kravik KL; Stokke T
Mol Cancer; 2006 May; 5():20. PubMed ID: 16709241
[TBL] [Abstract][Full Text] [Related]
13. Identification of 5-fluorouracil-inducible target genes using cDNA microarray profiling.
Maxwell PJ; Longley DB; Latif T; Boyer J; Allen W; Lynch M; McDermott U; Harkin DP; Allegra CJ; Johnston PG
Cancer Res; 2003 Aug; 63(15):4602-6. PubMed ID: 12907638
[TBL] [Abstract][Full Text] [Related]
14. Nm23-H1 suppresses tumor cell motility by down-regulating the lysophosphatidic acid receptor EDG2.
Horak CE; Lee JH; Elkahloun AG; Boissan M; Dumont S; Maga TK; Arnaud-Dabernat S; Palmieri D; Stetler-Stevenson WG; Lacombe ML; Meltzer PS; Steeg PS
Cancer Res; 2007 Aug; 67(15):7238-46. PubMed ID: 17671192
[TBL] [Abstract][Full Text] [Related]
15. Noninvasive detection of lentiviral-mediated choline kinase targeting in a human breast cancer xenograft.
Krishnamachary B; Glunde K; Wildes F; Mori N; Takagi T; Raman V; Bhujwalla ZM
Cancer Res; 2009 Apr; 69(8):3464-71. PubMed ID: 19336572
[TBL] [Abstract][Full Text] [Related]
16. Silencing of the annexin II gene down-regulates the levels of S100A10, c-Myc, and plasmin and inhibits breast cancer cell proliferation and invasion.
Zhang J; Guo B; Zhang Y; Cao J; Chen T
Saudi Med J; 2010 Apr; 31(4):374-81. PubMed ID: 20383413
[TBL] [Abstract][Full Text] [Related]
17. Identification of novel genes associated with the response to 5-FU treatment in gastric cancer cell lines using a cDNA microarray.
Park JS; Young Yoon S; Kim JM; Yeom YI; Kim YS; Kim NS
Cancer Lett; 2004 Oct; 214(1):19-33. PubMed ID: 15331170
[TBL] [Abstract][Full Text] [Related]
18. Down-regulation of type I insulin-like growth factor receptor increases sensitivity of breast cancer cells to insulin.
Zhang H; Pelzer AM; Kiang DT; Yee D
Cancer Res; 2007 Jan; 67(1):391-7. PubMed ID: 17210722
[TBL] [Abstract][Full Text] [Related]
19. Apoptosis, cell cycle progression and gene expression in TP53-depleted HCT116 colon cancer cells in response to short-term 5-fluorouracil treatment.
Adamsen BL; Kravik KL; Clausen OP; De Angelis PM
Int J Oncol; 2007 Dec; 31(6):1491-500. PubMed ID: 17982676
[TBL] [Abstract][Full Text] [Related]
20. Activation of choline kinase by extracellular Ca2+ is Ca(2+)-sensing receptor, Galpha12 and Rho-dependent in breast cancer cells.
Huang C; Hydo LM; Liu S; Miller RT
Cell Signal; 2009 Dec; 21(12):1894-900. PubMed ID: 19716891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
